Michael Kaltenborn is an experienced executive currently serving as the Chief Strategy and Corporate Development Officer at Karo Healthcare since February 2023, where responsibilities include Strategy, Business Development & Licensing, M&A, Separation/Integration, and Legal in a digitally first Fast Moving Consumer Healthcare platform. Previously, Kaltenborn spent over 15 years at Bayer, culminating in the role of Global Head of M&A for Consumer Health, leading global M&A activities for one of the world's top consumer health companies and acting as America's Hub Leader for BD&L, M&A, and Separation & Integration. Earlier career experience includes a managerial role at EY from 2002 to 2007 and a graduate education culminating in a Master's degree in Business Administration from the University of Münster, complemented by further studies at IMD from 2017 to 2020.